Dr. Janet D. Rowley Chronic Myeloid Leukemia CML
Dr. Janet Davison Rowley (born in 1925) is the first scientist to identify a chromosomal translocation as the cause of leukemia and other cancers. Dr. Rowley made the breakthrough discovery in 1972 of two translocations in leukemia, the 8:21 translocation in acute myelogenous leukemia (AML) and the 9:22 translocation in chronic myelogenous leukemia (CML).
VIDEOS
From Chromosomes To Cures: The Lifesaving Cancer Research Of Dr. Janet Rowley
February 21, 2013, Chicago Blood Cancer
2012 (28th) Japan Prize: Dr. Rowley / Dr. Druker / Dr. Lydon
April 24, 2012, JapanPrize
Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
January 24, 2012, EurekAlert
Janet Rowley's Vision: Treating Cancer at the Molecular Level
December 12, 2011, University of Chicago Medical Center
CML - Pathways to Discovery - Dr. Janet D. Rowley
September 22, 2011, National CML Society
Celebrating Janet D. Rowley, MD
December 15, 2019, University of Chicago Medical Center
Interview with Janet D. Rowley, M.D., D.Sc.
April 18, 2010, AACRNews
Janet Rowley Receives Presidential Medal of Freedom for Cancer Chromosome Studies
October 9, 2009, UniversityChicagoMedicalCenter
ARTICLES
Fathers (and Mothers) of Hematology
September 16, 2019, ASH Clinical news
Janet D. Rowley dies; linked genetics, cancer
December 21, 2013, The Washington post
Janet Rowley shares prestigious medical prize with cancer treatment pioneers
April 17, 2013, UChicagoNews
Named professorship to honor cancer researcher Janet Rowley, MD
May 24th, 2012, The University of Chicago Medicine
The Matriarch of Modern Cancer Genetics
February 7, 2011, The New York Times
A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
June 1, 1973, Nature
Fathers (and Mothers) of Hematology
September 16, 2019, ASH Clinical news
Janet D. Rowley dies; linked genetics, cancer
December 21, 2013, The Washington post
Janet Rowley shares prestigious medical prize with cancer treatment pioneers
April 17, 2013, UChicagoNews
Named professorship to honor cancer researcher Janet Rowley, MD
May 24th, 2012, The University of Chicago Medicine
The Matriarch of Modern Cancer Genetics
February 7, 2011, The New York Times
A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
June 1, 1973, Nature
Modes of access to the website
1 - Public access (strongly recommended)
On several occasions, the CML patient called CMLer will need a password to access several modules of the website.
(No registration required - Anonymous access)
1 - Public access (strongly recommended)
On several occasions, the CML patient called CMLer will need a password to access several modules of the website.
(No registration required - Anonymous access)
2 - Reserved access to CMLeukemia private group
On other occasions, the more experienced patients will need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
(Member password required and registration required).
On other occasions, the more experienced patients will need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
(Member password required and registration required).
